Can Epidermal Growth Factor Receptor Improve the Postoperative Survivorship for Inoperable Non-small Cell Lung Cancer With Spinal Metastasis ?

• Status: Completed
• Trial end date: 2016-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Not significantly increased survival in T/T

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taipei Veterans General Hospital, Taiwan
• Treatments: Gefitinib; Mitogens

Criteria

Inclusion Criteria:

• NSCLC with spinal metastasis

Exclusion Criteria:

• brain metastasis and expected survival < 3 months